RNA Targeting Small Molecules Therapeutics Global Research Report 2025: 7.03 Billion Market Opportunities and Strategies to 2034 - Expansion in AI-driven Drug Discovery, Alliances, Emergin...
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
diseases, drug discovery, and pharma-biotech sectors. Expansion in AI-driven drug discovery, strategic alliances, and emerging markets offers additional potential for growth, especially in the USA. Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The "RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's offering. This report describes and explains the RNA targeting small molecules therapeutics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global RNA targeting small molecules therapeutics market reached a value of nearly $2.77 billion in 2024, having grown at a compound annual growth rate (CAGR) of 31.74% since 2019. The market is expected to grow from $2.77 billion in 2024 to $4.13 billion in 2029 at a rate of 8.28%. The market is then
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.MarketBeat
- Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Why Hall Of Famer Terrell Davis Is Talking About The ‘Other TD' [Forbes]Forbes
- With 72% ownership in Teva Pharmaceutical Industries Limited (NYSE:TEVA), institutional investors have a lot riding on the business [Yahoo! Finance]Yahoo! Finance
- Is Teva a Bargain After 27% Surge and Cost-Cutting Headlines? [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 11/5/25 - Beat
TEVA
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form 4
- 11/26/25 - Form 144
- TEVA's page on the SEC website